stockcue

NTLA (Intellia Therapeutics, Inc.): risk score 46/100 — Hold · Valuation 22/100 · Financial health 67/100 · Growth 48/100 · price $14.07. Full report with peer comparison, earnings trends and AI analysis below.

Fetching report — first lookup can take ~5s